Skip to main content
. 2018 Aug 7;41(5):527–539. doi: 10.1007/s13402-018-0390-8

Fig. 3.

Fig. 3

Low ALDH2 expression predicts a poor prognosis in lung cancer. a Boxplot representing the overall variation in XRCC1 and ALDH2 mRNA levels in lung cancers (Oncomine). b Kaplan-Meier analysis of the 5-year overall survival of lung cancer patients (TCGA) stratified for XRCC1 mRNA levels (cut at the median). c Kaplan-Meier analysis of the 5-year overall survival of lung cancer patients (TCGA) stratified for ALDH2 mRNA levels (cut at the median)